Benzodiazepine and z-hypnotic prescribing from acute psychiatric inpatient discharge to long-term care in the community.
Chris F JohnsonOla Ali NassrCatherine HarpurDavid KenicerAlex ThomGazala AkramPublished in: Pharmacy practice (2018)
One in three patients were prescribed a benzodiazepine or z-hypnotics at discharge with 1 in 5 receiving continuous long-term treatment (prescriptions) for 12 months post-discharge. As chronic long-term B-Z prescribing and use still remains an issue, future strategies using routine patient-level prescribing data may support prescribers to review and minimise inappropriate long-term prescribing.
Keyphrases
- primary care
- long term care
- mental health
- end stage renal disease
- adverse drug
- ejection fraction
- healthcare
- chronic kidney disease
- prognostic factors
- palliative care
- liver failure
- emergency department
- peritoneal dialysis
- case report
- intensive care unit
- electronic health record
- combination therapy
- current status
- extracorporeal membrane oxygenation
- deep learning
- artificial intelligence